A multi-center study revealed adalimumab weekly dose escalation successfully controlled #uveitis & reduced corticosteroid use in most patients at 6-months, particularly for those with posterior uveitis, but less so in panuveitis.
@EdmundTsuiMD@UCLASteinEye@GangaputraSapna@KareemMoussaMD
https://t.co/QsrAM71ReC
#ophthalmology
Check out our newest paper in @AAOjournal evaluating efficacy of escalating to weekly adalimumab for treatment of #uveitis.
➡️50 patients from 6 centers
➡️52% had treatment success after escalation
➡️Posterior uveitis had higher success rates
https://t.co/lhtxFnYBPS
Accidentally hit the lens with your intravitreal bevacizumab injection? The lens might survive without need for surgery: https://t.co/mjxEg8dL7I
@AAOjournal
Happy to share our outcomes using suprachoroidal triamcinolone in eyes with uveitis in @AJOphthalmology. Link below provides free access:
https://t.co/vE3qoSkMvl
@drmarirodriguez @drmarirodriguez I recently stuck with a book I did not like till the end, hoping it would get better, and I regretted it. I say cut your losses and move on! 😉